Diabetes
Conditions
Brief summary
Type 1 and Type 2 are the most common types of diabetes mellitus. Although the cause of Type 1 is different to Type 2, they can both lead to high blood glucose levels as the patient is unable to store and use sugar. The disease is an epidemic of the 21st century which is increasing, having a current prevalence of approximately 8%. Poor disease control is associated with a range of long-term health conditions which have a severe impact upon quality of life and are responsible for the increased morbidity and mortality associated with the disease. Healthcare professionals use HbA1c as the main marker to monitor diabetic control. Patients with diabetes have regular review appointments to monitor their overall health and discuss their HbA1c target and results. The purpose of monitoring patients with diabetes is to improve patient outcomes. It is known that poor control is associated with poor clinical outcomes and also that reduced monitoring is linked to suboptimal diabetic control. Therefore, aiming for the correct monitoring frequency helps towards achieving the best control which can lead to the most favourable clinical outcomes. The inconvenience of attending for a blood test and follow-up appointment is a major factor affecting patient adherence to monitoring, locally approximately 50% of patients with diabetes have their HbA1c level measured either too soon or too late. To address this issue and improve access to monitoring at the correct time interval we aim to produce a HbA1c home testing kit which can be posted back to the laboratory at the convenience of the patient. The kit will be developed based on feedback from patients with diabetes and will use a dried blood spot sample to produce HbA1c results comparable to the whole blood standard method.
Interventions
DEVICEDried blood spot device
Patients will be asked to provide a dried blood spot sample
OTHERHealthcare professional interviews
Health care professionals only will be interviewed using the topic guide and asked about their experience of diabetes monitoring
Sponsors
University Hospitals of North Midlands NHS Trust
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
* Diagnosis of Type I or Type II diabetes * Aged 18 years or over * Venous blood sample for HbA1c collected within the two weeks prior to the clinic appointment * Ability to provide fully informed consent
Exclusion criteria
* Non-English speaking where translation of the study documents and procedures could limit fully informed consent * Severe visual impairment which would leave the participant unable to complete the study procedures.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| DBS kit assay performance | 1 year, 3 months | For the DBS-based home collection kit used by patients to be 'fit for purpose', it must achieve the following: Assay performance - correlation and bias. Correlation coefficient (r2 value) from linear regression plot should be \>0.95 with a bias of less than 5%. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Participant questionnaires theme analysis | 1 year, 3 months | Completed participant questionnaires will be collated and analysed for themes. We aim to determine whether participants deem the home-collection kit to be acceptable. The information gained will be used to design a full study. |
| Interviews | 1 year, 3 months | The health care professional interview transcripts will be recorded and analysed. The emerging themes will be taken into consideration when designing the full study. |
Countries
United Kingdom
Outcome results
None listed